14 , 15 Though these findings are promising, the sample sizes are very small, many of the studies focused on specific products, including synthetic cannabinoids, and confidence intervals span close to the level of significance. 14 Thus, we have very limited evidence regarding the efficacy of products available to patients in states with medical cannabis, including the relative benefits of THC, CBD, or various THC/CBD ratios for pain.
1
—
—